AnaptysBio
ANAB
116 hedge funds and large institutions have $545M invested in AnaptysBio in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 14 closing their positions.
0.08% more ownership
Funds ownership: 114.12% → 114.2% (+0.08%)
0% more funds holding
Funds holding: 116 → 116 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
6% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.07M
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
11% less capital invested
Capital invested by funds: $615M → $545M (-$70.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$25.7M |
| 2 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$11M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$9.15M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$8.94M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$12.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.8M |
| 3 |
DM
Deerfield Management
New York
|
-$12.5M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.95M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.33M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BRWA
126
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$236K | -11,625 | Closed |
|
127
Tudor Investment Corp
Stamford,
Connecticut
| – | -$210K | -10,307 | Closed |
|
|
QT
128
Quantbot Technologies
New York
| – | -$93.2K | -4,581 | Closed |
|
|
CG
129
Cutler Group
San Francisco,
California
| – | -$30K | -1,500 | Closed |
|
|
IA
130
IFP Advisors
Tampa,
Florida
| – | -$366 | -18 | Closed |
|
ANAB Hedge Fund Activity: Q3 2023 in Review
116 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2023, worth a combined $545M — down 11% from $615M a quarter earlier.
Fund positioning in ANAB was balanced in Q3 2023: 14 funds opened new positions, 14 closed out, 34 added to existing stakes and 38 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $25.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $12.8M.
- 116 institutional investors held AnaptysBio (ANAB) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $545M of AnaptysBio stock for Q3 2023, down 11% quarter-over-quarter.
- 14 funds opened new AnaptysBio positions in Q3 2023 and 14 closed out, a net change of 0 holders.
- The largest AnaptysBio buyer in Q3 2023 was Deep Track Capital, an estimated $25.7M added.
- The largest AnaptysBio seller in Q3 2023 was Baker Bros. Advisors, an estimated $12.8M sold.
Based on aggregated 13F filings for Q3 2023.